Copyright Reports & Markets. All rights reserved.

Global Non-invasive Continuous Glucose Monitor Market Research Report 2021

Request for Sample of this report
Buy now

1 Non-invasive Continuous Glucose Monitor Market Overview

  • 1.1 Product Overview and Scope of Non-invasive Continuous Glucose Monitor
  • 1.2 Non-invasive Continuous Glucose Monitor Segment by Type
    • 1.2.1 Global Non-invasive Continuous Glucose Monitor Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Wearable
    • 1.2.3 Not wearable
  • 1.3 Non-invasive Continuous Glucose Monitor Segment by Application
    • 1.3.1 Global Non-invasive Continuous Glucose Monitor Sales Comparison by Application: (2021-2027)
    • 1.3.2 Hospital
    • 1.3.3 Clinic
    • 1.3.4 Other
  • 1.4 Global Non-invasive Continuous Glucose Monitor Market Size Estimates and Forecasts
    • 1.4.1 Global Non-invasive Continuous Glucose Monitor Revenue 2016-2027
    • 1.4.2 Global Non-invasive Continuous Glucose Monitor Sales 2016-2027
    • 1.4.3 Non-invasive Continuous Glucose Monitor Market Size by Region: 2016 Versus 2021 Versus 2027

2 Non-invasive Continuous Glucose Monitor Market Competition by Manufacturers

  • 2.1 Global Non-invasive Continuous Glucose Monitor Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Non-invasive Continuous Glucose Monitor Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Non-invasive Continuous Glucose Monitor Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Non-invasive Continuous Glucose Monitor Manufacturing Sites, Area Served, Product Type
  • 2.5 Non-invasive Continuous Glucose Monitor Market Competitive Situation and Trends
    • 2.5.1 Non-invasive Continuous Glucose Monitor Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Non-invasive Continuous Glucose Monitor Players Market Share by Revenue
    • 2.5.3 Global Non-invasive Continuous Glucose Monitor Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Non-invasive Continuous Glucose Monitor Retrospective Market Scenario by Region

  • 3.1 Global Non-invasive Continuous Glucose Monitor Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.2 Global Non-invasive Continuous Glucose Monitor Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.3 North America Non-invasive Continuous Glucose Monitor Market Facts & Figures by Country
    • 3.3.1 North America Non-invasive Continuous Glucose Monitor Sales by Country
    • 3.3.2 North America Non-invasive Continuous Glucose Monitor Revenue by Country
    • 3.3.3 United States
    • 3.3.4 Canada
  • 3.4 Europe Non-invasive Continuous Glucose Monitor Market Facts & Figures by Country
    • 3.4.1 Europe Non-invasive Continuous Glucose Monitor Sales by Country
    • 3.4.2 Europe Non-invasive Continuous Glucose Monitor Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Non-invasive Continuous Glucose Monitor Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Non-invasive Continuous Glucose Monitor Sales by Region
    • 3.5.2 Asia Pacific Non-invasive Continuous Glucose Monitor Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
  • 3.6 Latin America Non-invasive Continuous Glucose Monitor Market Facts & Figures by Country
    • 3.6.1 Latin America Non-invasive Continuous Glucose Monitor Sales by Country
    • 3.6.2 Latin America Non-invasive Continuous Glucose Monitor Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
    • 3.6.6 Colombia
  • 3.7 Middle East and Africa Non-invasive Continuous Glucose Monitor Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Non-invasive Continuous Glucose Monitor Sales by Country
    • 3.7.2 Middle East and Africa Non-invasive Continuous Glucose Monitor Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Non-invasive Continuous Glucose Monitor Historic Market Analysis by Type

  • 4.1 Global Non-invasive Continuous Glucose Monitor Sales Market Share by Type (2016-2021)
  • 4.2 Global Non-invasive Continuous Glucose Monitor Revenue Market Share by Type (2016-2021)
  • 4.3 Global Non-invasive Continuous Glucose Monitor Price by Type (2016-2021)

5 Global Non-invasive Continuous Glucose Monitor Historic Market Analysis by Application

  • 5.1 Global Non-invasive Continuous Glucose Monitor Sales Market Share by Application (2016-2021)
  • 5.2 Global Non-invasive Continuous Glucose Monitor Revenue Market Share by Application (2016-2021)
  • 5.3 Global Non-invasive Continuous Glucose Monitor Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Dexcom
    • 6.1.1 Dexcom Corporation Information
    • 6.1.2 Dexcom Description and Business Overview
    • 6.1.3 Dexcom Non-invasive Continuous Glucose Monitor Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Dexcom Non-invasive Continuous Glucose Monitor Product Portfolio
    • 6.1.5 Dexcom Recent Developments/Updates
  • 6.2 Abbott Laboratories
    • 6.2.1 Abbott Laboratories Corporation Information
    • 6.2.2 Abbott Laboratories Description and Business Overview
    • 6.2.3 Abbott Laboratories Non-invasive Continuous Glucose Monitor Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Abbott Laboratories Non-invasive Continuous Glucose Monitor Product Portfolio
    • 6.2.5 Abbott Laboratories Recent Developments/Updates
  • 6.3 Medtronic
    • 6.3.1 Medtronic Corporation Information
    • 6.3.2 Medtronic Description and Business Overview
    • 6.3.3 Medtronic Non-invasive Continuous Glucose Monitor Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Medtronic Non-invasive Continuous Glucose Monitor Product Portfolio
    • 6.3.5 Medtronic Recent Developments/Updates
  • 6.4 Senseonics Holdings
    • 6.4.1 Senseonics Holdings Corporation Information
    • 6.4.2 Senseonics Holdings Description and Business Overview
    • 6.4.3 Senseonics Holdings Non-invasive Continuous Glucose Monitor Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Senseonics Holdings Non-invasive Continuous Glucose Monitor Product Portfolio
    • 6.4.5 Senseonics Holdings Recent Developments/Updates
  • 6.5 Know Labs
    • 6.5.1 Know Labs Corporation Information
    • 6.5.2 Know Labs Description and Business Overview
    • 6.5.3 Know Labs Non-invasive Continuous Glucose Monitor Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Know Labs Non-invasive Continuous Glucose Monitor Product Portfolio
    • 6.5.5 Know Labs Recent Developments/Updates
  • 6.6 Huzhou Meiqi Medical Devices
    • 6.6.1 Huzhou Meiqi Medical Devices Corporation Information
    • 6.6.2 Huzhou Meiqi Medical Devices Description and Business Overview
    • 6.6.3 Huzhou Meiqi Medical Devices Non-invasive Continuous Glucose Monitor Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Huzhou Meiqi Medical Devices Non-invasive Continuous Glucose Monitor Product Portfolio
    • 6.6.5 Huzhou Meiqi Medical Devices Recent Developments/Updates
  • 6.7 San Meditech
    • 6.6.1 San Meditech Corporation Information
    • 6.6.2 San Meditech Description and Business Overview
    • 6.6.3 San Meditech Non-invasive Continuous Glucose Monitor Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 San Meditech Non-invasive Continuous Glucose Monitor Product Portfolio
    • 6.7.5 San Meditech Recent Developments/Updates
  • 6.8 Roche
    • 6.8.1 Roche Corporation Information
    • 6.8.2 Roche Description and Business Overview
    • 6.8.3 Roche Non-invasive Continuous Glucose Monitor Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 Roche Non-invasive Continuous Glucose Monitor Product Portfolio
    • 6.8.5 Roche Recent Developments/Updates
  • 6.9 LifeScan, Inc.
    • 6.9.1 LifeScan, Inc. Corporation Information
    • 6.9.2 LifeScan, Inc. Description and Business Overview
    • 6.9.3 LifeScan, Inc. Non-invasive Continuous Glucose Monitor Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 LifeScan, Inc. Non-invasive Continuous Glucose Monitor Product Portfolio
    • 6.9.5 LifeScan, Inc. Recent Developments/Updates
  • 6.10 Insulet Corporation
    • 6.10.1 Insulet Corporation Corporation Information
    • 6.10.2 Insulet Corporation Description and Business Overview
    • 6.10.3 Insulet Corporation Non-invasive Continuous Glucose Monitor Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 Insulet Corporation Non-invasive Continuous Glucose Monitor Product Portfolio
    • 6.10.5 Insulet Corporation Recent Developments/Updates
  • 6.11 Panasonic
    • 6.11.1 Panasonic Corporation Information
    • 6.11.2 Panasonic Non-invasive Continuous Glucose Monitor Description and Business Overview
    • 6.11.3 Panasonic Non-invasive Continuous Glucose Monitor Sales, Revenue and Gross Margin (2016-2021)
    • 6.11.4 Panasonic Non-invasive Continuous Glucose Monitor Product Portfolio
    • 6.11.5 Panasonic Recent Developments/Updates
  • 6.12 Echo Therapeutics
    • 6.12.1 Echo Therapeutics Corporation Information
    • 6.12.2 Echo Therapeutics Non-invasive Continuous Glucose Monitor Description and Business Overview
    • 6.12.3 Echo Therapeutics Non-invasive Continuous Glucose Monitor Sales, Revenue and Gross Margin (2016-2021)
    • 6.12.4 Echo Therapeutics Non-invasive Continuous Glucose Monitor Product Portfolio
    • 6.12.5 Echo Therapeutics Recent Developments/Updates
  • 6.13 Tandem Diabetes Care
    • 6.13.1 Tandem Diabetes Care Corporation Information
    • 6.13.2 Tandem Diabetes Care Non-invasive Continuous Glucose Monitor Description and Business Overview
    • 6.13.3 Tandem Diabetes Care Non-invasive Continuous Glucose Monitor Sales, Revenue and Gross Margin (2016-2021)
    • 6.13.4 Tandem Diabetes Care Non-invasive Continuous Glucose Monitor Product Portfolio
    • 6.13.5 Tandem Diabetes Care Recent Developments/Updates

7 Non-invasive Continuous Glucose Monitor Manufacturing Cost Analysis

  • 7.1 Non-invasive Continuous Glucose Monitor Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Non-invasive Continuous Glucose Monitor
  • 7.4 Non-invasive Continuous Glucose Monitor Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Non-invasive Continuous Glucose Monitor Distributors List
  • 8.3 Non-invasive Continuous Glucose Monitor Customers

9 Non-invasive Continuous Glucose Monitor Market Dynamics

  • 9.1 Non-invasive Continuous Glucose Monitor Industry Trends
  • 9.2 Non-invasive Continuous Glucose Monitor Growth Drivers
  • 9.3 Non-invasive Continuous Glucose Monitor Market Challenges
  • 9.4 Non-invasive Continuous Glucose Monitor Market Restraints

10 Global Market Forecast

  • 10.1 Non-invasive Continuous Glucose Monitor Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Non-invasive Continuous Glucose Monitor by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Non-invasive Continuous Glucose Monitor by Type (2022-2027)
  • 10.2 Non-invasive Continuous Glucose Monitor Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Non-invasive Continuous Glucose Monitor by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Non-invasive Continuous Glucose Monitor by Application (2022-2027)
  • 10.3 Non-invasive Continuous Glucose Monitor Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Non-invasive Continuous Glucose Monitor by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Non-invasive Continuous Glucose Monitor by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Wearable
    Not wearable

    Segment by Application
    Hospital
    Clinic
    Other

    By Region
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Latin America
    Mexico
    Brazil
    Argentina
    Colombia
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    Dexcom
    Abbott Laboratories
    Medtronic
    Senseonics Holdings
    Know Labs
    Huzhou Meiqi Medical Devices
    San Meditech
    Roche
    LifeScan, Inc.
    Insulet Corporation
    Panasonic
    Echo Therapeutics
    Tandem Diabetes Care

    Buy now